Inapure 5 Tablet contains Ivabradine 5 mg, a selective sinus node inhibitor used primarily for the management of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, leading to a reduction in heart rate without affecting myocardial contractility or intracardiac conduction. This mechanism helps to decrease myocardial oxygen demand, thereby alleviating angina symptoms and improving exercise tolerance. Inapure 5 is indicated for patients with stable angina who are in sinus rhythm and have a heart rate above 70 beats per minute, particularly when beta-blockers are contraindicated or insufficient. Additionally, it is utilized in the treatment of chronic heart failure with reduced ejection fraction to reduce the risk of hospitalization due to worsening heart failure. The recommended dosage and duration of therapy should be individualized based on clinical response and patient tolerance. Inapure 5 is contraindicated in patients with acute decompensated heart failure, severe hypotension, sick sinus syndrome, or pacemaker dependence. Common adverse effects include bradycardia, luminous phenomena, and headache. Regular monitoring of heart rate and clinical status is advised to optimize therapeutic outcomes and minimize potential risks.